Osteosarcoma is a relatively uncommon tumor that is defined histologically by malignant cells developing osteoid. Osteosarcomas are mesenchymal cell tumors that cause abnormal bone growth. A combination of genetic, epigenetic, and environmental factors leads mesenchymal stem cells to develop into bone precursor cells, resulting in osteosarcoma. Only tumor suppressor genes, such as p53, Rb, RECQL4, BLM, and WRN, have been detected in inherited family illnesses with an OS susceptibility. These genes, in particular, play an essential role in the development of OS in individuals. In this research, core genes responsible for OS were determined using a microarray and systems biology. 234 genes encoding overexpression and down-regulation were identified, among which 60 were considered as key genes, many of which had known roles in bone growth. Transcriptional regulatory networks were developed with this data and subsequently partitioned to define cis-regulatory modules. Results indicate that several OS-specific genes have strongly conserved the clustering of bone-related cis-regulatory modules, thus promoting the hypothesis that a bone-related gene network is essential for understanding OS biology and may play a role in bone contractility and anomalies.

Download full-text PDF

Source
http://dx.doi.org/10.5650/jos.ess21327DOI Listing

Publication Analysis

Top Keywords

transcriptional regulatory
8
regulatory networks
8
systems biology
8
bone growth
8
cis-regulatory modules
8
genes
6
identification analysis
4
analysis transcriptional
4
networks osteosarcoma
4
osteosarcoma microarray
4

Similar Publications

Inflammation and Immune Escape in Ovarian Cancer: Pathways and Therapeutic Opportunities.

J Inflamm Res

January 2025

Precision Medicine Laboratory, School of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang, People's Republic of China.

Ovarian cancer (OC) remains one of the most lethal gynecological malignancies, largely due to its late-stage diagnosis and high recurrence rates. Chronic inflammation is a critical driver of OC progression, contributing to immune evasion, tumor growth, and metastasis. Inflammatory cytokines, including IL-6, TNF-α, and IL-8, as well as key signaling pathways such as nuclear factor kappa B (NF-kB) and signal transducer and activator of transcription 3 (STAT3), are upregulated in OC, promoting a tumor-promoting environment.

View Article and Find Full Text PDF

Background: While epidemiological data suggest a connection between atopic dermatitis (AD) and COVID-19, the molecular mechanisms underlying this relationship remain unclear.

Objective: To investigate whether COVID-19-related CpGs may contribute to AD development and whether this association is mediated through the regulation of specific genes' expression.

Methods: We combined Mendelian randomization and transcriptome analysis for data-driven explorations.

View Article and Find Full Text PDF

Van der Woude syndrome (VWS) is an autosomal dominant disorder characterized by lower lip pits and orofacial clefts (OFCs). With a prevalence of approximately 1 in 35,000 live births, it is the most common form of syndromic clefting and may account for ~2% of all OFCs. The majority of VWS is attributed to genetic variants in IRF6 (~70%) or GRHL3 (~5%), leaving up to 25% of individuals with VWS without a molecular diagnosis.

View Article and Find Full Text PDF

Characterization of tumor epigenetic aberrations is integral to understanding the mechanisms of tumorigenesis and provide diagnostic, prognostic, and predictive information of high clinical relevance. Among the different tumor-associated epigenetic signatures, 5 methyl-cytosine (5mC) and 5-hydroxymethylcytosine (5hmC) are the two most well-characterized DNA methylation alterations linked to cancer pathogenesis. 5hmC has a tissue-specific distribution and its abundance is subjected to changes in tumor DNA, making it a promising biomarker.

View Article and Find Full Text PDF

Background: Uterine injury can cause uterine scarring, leading to a series of complications that threaten women's health. Uterine healing is a complex process, and there are currently no effective treatments. Although our previous studies have shown that bone marrow mesenchymal stem cells (BMSCs) promote uterine damage repair, the underlying mechanisms remain unclear.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!